Feasibility study of cap-assisted endoscopic mucosal resection for gastric adenocarcinoma of fundic gland type
Gastric Cancer · 2026
DOI: 10.1007/s10120-026-01762-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastric Cancer, 2026. Verfasst von Risa Ashizaki und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo,…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma, Endoscopic Mucosal Resection, Gastric Fundus. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kobe University.
Abstract (Originalsprache)
Background
Gastric adenocarcinoma of fundic gland type (GA-FG) is a rare subtype that typically arises in the upper stomach, making endoscopic submucosal dissection (ESD) technically challenging. Cap-assisted endoscopic mucosal resection (EMRC) is widely used for early gastric cancer due to its shorter procedure time and improved safety profile. We evaluated its efficacy and safety for GA-FG.
Methods
We retrospectively analyzed patients with GA-FG who underwent EMRC or ESD between April 2013 and September 2024. Outcomes included en bloc, complete, and curative resection rates; procedure time; and adverse events. Odds ratios (ORs) were estimated using logistic regression, and inverse probability of treatment weighting was applied for adjustment.
Results
We enrolled 70 patients with 77 lesions that were treated by EMRC ( n = 57) or ESD ( n = 20). En bloc resection was achieved in 100% of both groups. Complete resection rates were 96.5% for EMRC and 100% for ESD ( P = 1.00). The EMRC group had significantly shorter median procedure time (6 vs. 46 min, P < 0.001) and fewer adverse events (OR 0.05, 95% CI 0.003–0.36; P = 0.002). No significant differences were found in curative resection (OR 3.47, 95% CI 0.86–14.08; P = 0.08) and intraoperative perforation (10% in the ESD group, 0% in the EMRC group; P = 0.06).
Conclusions
Our findings suggest that EMRC is a safe and effective treatment for GA-FG, offering shorter procedure times and a lower risk of complications compared with ESD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
- Department of Internal Medicine, Nishiwaki Municipal Hospital, Nishiwaki, Japan.
- Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. yoshizak@med.kobe-u.ac.jp.
- Department of Medical Device Engineering, Kobe University Graduate School of Medicine, Kobe, Japan.
- Asahara Clinic, Akashi, Japan.
Förderung
- Kobe University
Zitieren
APA
Ashizaki, R., Yoshizaki, T., Higasa, Y., Tanabe, H., Nishikawa, E., Hoki, S., Ishida, R., Hori, H., Nakai, T., Ueda, C., Urakami, S., Abe, H., Takao, M., Takao, T., Asahara, M., Morita, Y., Toyonaga, T., & Kodama, Y. (2026). Feasibility study of cap-assisted endoscopic mucosal resection for gastric adenocarcinoma of fundic gland type. Gastric Cancer. https://doi.org/10.1007/s10120-026-01762-7
Vancouver
Ashizaki R, Yoshizaki T, Higasa Y, Tanabe H, Nishikawa E, Hoki S, et al. Feasibility study of cap-assisted endoscopic mucosal resection for gastric adenocarcinoma of fundic gland type. Gastric Cancer. 2026. doi:10.1007/s10120-026-01762-7
BibTeX
@article{Ashizaki2026,
author = {Ashizaki, Risa and Yoshizaki, Tetsuya and Higasa, Yuta and Tanabe, Hiroshi and Nishikawa, Eri and Hoki, Shinya and Ishida, Ryosuke and Hori, Hitomi and Nakai, Tatsuya and Ueda, Chise and Urakami, Satoshi and Abe, Hirofumi and Takao, Madoka and Takao, Toshitatsu and Asahara, Masakyo and Morita, Yoshinori and Toyonaga, Takashi and Kodama, Yuzo},
title = {Feasibility study of cap-assisted endoscopic mucosal resection for gastric adenocarcinoma of fundic gland type},
journal = {Gastric Cancer},
year = {2026},
doi = {10.1007/s10120-026-01762-7}
}
EUVIMED